Taysha Gene Therapies Disclosed That It Has Commenced An Underwritten Public Offering Of Up To $75M Of Shares Of Its Common Stock And, In Lieu Of Common Stock To Certain Investors That So Choose, Pre-funded Warrants To Purchase Shares Of Its Common Stock
$TSHA
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Taysha Gene Therapies Disclosed That It Has Commenced An Underwritten Public Offering Of Up To $75M Of Shares Of Its Common Stock And, In Lieu Of Common Stock To Certain Investors That So Choose, Pre-funded Warrants To Purchase Shares Of Its Common Stock